UPDATES ON HEART FAILURE PHENOTYPES

Saturday, March 8, 2025

8:00 AM – 10:30 AM ET

Moderator(s)

Mark R. Hofmeyer, MD, FACC

Attending Physician - Advanced Heart Failure Associate Professor - Georgetown University School of Medicine
MedStar Health
Washington, District of Columbia, United States

Disclosure(s): No financial relationships to disclose
Mandeep R. Mehra, MD, MSc, FRCP

William Harvey Chair in Cardiovascular Medicine
Brigham and Women's Hospital
Needham, Minnesota, United States

Disclosure(s): Abbott Labs: Consultant (Ongoing), Grant/Research Support (Ongoing); Cadrenal: Consultant (Ongoing); Fineheart: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); FIRE-1: Consultant (Ongoing); leviticus: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Moderna: Consultant (Ongoing); NupulseCV: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Paragonix Therapeutics, Inc.: Consultant (Ongoing); TransMedics (Organ Transplant ) TMDX : NASDQ: Consultant (Ongoing), Stock-publicly held company (excluding mutual/index funds) (Ongoing)
Ileana L. Pina, MD, MPH

Professor of Medicine
Thomas Jefferson University
Cleveland hts, Ohio, United States

Disclosure information not submitted.

Disclosure(s):

Mark R. Hofmeyer, MD, FACC: No financial relationships to disclose

Mandeep R. Mehra, MD, MSc, FRCP: Abbott Labs: Consultant (Ongoing), Grant/Research Support (Ongoing); Cadrenal: Consultant (Ongoing); Fineheart: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); FIRE-1: Consultant (Ongoing); leviticus: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Moderna: Consultant (Ongoing); NupulseCV: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Paragonix Therapeutics, Inc.: Consultant (Ongoing); TransMedics (Organ Transplant ) TMDX : NASDQ: Consultant (Ongoing), Stock-publicly held company (excluding mutual/index funds) (Ongoing)